An overview of the antimicrobial resistance mechanisms of bacteria

被引:934
作者
Reygaert, Wanda C. [1 ]
机构
[1] Oakland Univ, Dept Biomed Sci, William Beaumont Sch Med, Rochester, MI 48063 USA
来源
AIMS MICROBIOLOGY | 2018年 / 4卷 / 03期
关键词
antimicrobial resistance; beta-lactamase; MRSA; ESBL; CRE;
D O I
10.3934/microbiol.2018.3.482
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Resistance to antimicrobial agents has become a major source of morbidity and mortality worldwide. When antibiotics were first introduced in the 1900's, it was thought that we had won the war against microorganisms. It was soon discovered however, that the microorganisms were capable of developing resistance to any of the drugs that were used. Apparently most pathogenic microorganisms have the capability of developing resistance to at least some antimicrobial agents. The main mechanisms of resistance are: limiting uptake of a drug, modification of a drug target, inactivation of a drug, and active efflux of a drug. These mechanisms may be native to the microorganisms, or acquired from other microorganisms. Understanding more about these mechanisms should hopefully lead to better treatment options for infective diseases, and development of antimicrobial drugs that can withstand the microorganisms attempts to become resistant.
引用
收藏
页码:482 / 501
页数:20
相关论文
共 89 条
  • [1] Antibiotic resistant threats in the United States, 2013, ANT RES THREATS US
  • [2] Escherichia coli β-Lactamases: What Really Matters
    Bajaj, Priyanka
    Singh, Nambram S.
    Virdi, Jugsharan S.
    [J]. FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [3] Small multidrug resistance proteins: A multidrug transporter family that continues to grow
    Bay, Denice C.
    Rommens, Kenton L.
    Turner, Raymond J.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2008, 1778 (09): : 1814 - 1838
  • [4] Bebear C. M., 2005, Current Drug Targets - Infectious Disorders, V5, P263, DOI 10.2174/1568005054880109
  • [5] Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World?
    Beceiro, Alejandro
    Tomas, Maria
    Bou, German
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2013, 26 (02) : 185 - 230
  • [6] Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype
    Bevan, Edward R.
    Jones, Annie M.
    Hawkey, Peter M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (08) : 2145 - 2155
  • [7] Molecular mechanisms of antibiotic resistance
    Blair, Jessica M. A.
    Webber, Mark A.
    Baylay, Alison J.
    Ogbolu, David O.
    Piddock, Laura J. V.
    [J]. NATURE REVIEWS MICROBIOLOGY, 2015, 13 (01) : 42 - 51
  • [8] Blair JMA, 2014, FUTURE MICROBIOL, V9, P1165, DOI [10.2217/fmb.14.66, 10.2217/FMB.14.66]
  • [9] Antimicrobials as promoters of genetic variation
    Blazquez, Jesus
    Couce, Alejandro
    Rodriguez-Beltran, Jeronimo
    Rodriguez-Rojas, Alexandro
    [J]. CURRENT OPINION IN MICROBIOLOGY, 2012, 15 (05) : 561 - 569
  • [10] Updated Functional Classification of β-Lactamases
    Bush, Karen
    Jacoby, George A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (03) : 969 - 976